Ceo
CurrentAscelia is a specialty pharmaceutical company located in Malmö, Sweden dedicated to the development of novel medicines to improve the life expectancy and quality of life for people living with cancer. The Company’s strategy is to develop and make available to patients a portfolio of differentiated, underappreciated and de-risked medicinal product candidates addressing unmet medical needs in cancer and cancer-related diseases.Ascelia has two clinical stage product candidates under development: Mangoral and Oncoral.